While analogues of GLP-1, like exendin 4 or liraglutide, showed neuroprotective potential in models of Alzheimer’s [20] and Parkinson’s disease [19], [41], the effect in ALS mice so far has been insufficient. Here, GCG is linked to amyotrophic lateral sclerosis.